OncoDaily at ASCO 2026

OncoDiscovery Award - A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

Grand Rounds by OncoDaily: AI in Oncology Edition

Kelley Tuthill: 20th Annual Boston Hot Pink Party Raises $1.2 Million for Breast Cancer Research

Oncology News, Insights, Stories by OncoDaily

World Melanoma Day symposium
OncoDaily

World Melanoma Day Global Symposium

ASCO 2026
Voices

Attending ASCO 2026? Join the OncoDaily Ambassador Team

Joe Cocker Lung Cancer You Are So Beautiful OHasmik
Celebrities and Cancer

Joe Cocker and His Battle With Lung Cancer: The Voice That Defined a Generation

Miriam Mutebi: The Launch of a WHO Centre to Strengthen Cancer Health Systems

SMART Trial at ESMO Breast Cancer Annual Congress 2026: ctDNA Tool Predicts Progression Risk in Metastatic Breast Cancer

Empowering Oncologists: Why Survivorship Matters?

Richard Sullivan: Addressing the "Intellectual Wastelands" of Global Cancer Policy

Vincent Rajkumar: Updated mSMART Guidelines for Relapsed Myeloma

Caleb Lareau Secures 2026 Pershing Square Sohn Prize for Chemotherapy Innovation

PHERGain-2 Trial at ESMO Breast Cancer Congress 2026: Chemo-Free Strategy in HER2+ Early Breast Cancer

Voices
ASCO

Cannabis in Cancer Care: Navigating the Balance Between Relief and Risk - ASCO

Tunch Akmandor: Discussions Around Survivorship, Prevention, and Translational Oncology at ESMO Breast Cancer 2026

Miriam Knoll: Educational and Meaningful Visit from Nina Niu Sanford at Northwell Health

Patrick Soon-Shiong: The World’s First NK Cell Manufacturing Robot in Production

Highlights from the Closing Event of the Thyroid Cancer Awareness Campaign - Qatar Cancer Society

Douglas Flora: REDMOD Flagged Pancreatic Cancer an Average of 16 Months Before Diagnosis

Amy K. Patel: The Importance of Physicians Getting Involved in Advocacy Endeavors

FDA Approvals
Daraxonrasib

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy

Resonance

15 May
Immunotherapy

NCCN 2026 Policy Summit: Innovations in Cancer Care Through the Ages

The National Comprehensive Cancer Network

25 Jun
NCCN

NCCN Global Policy Webinar - The Growing Cancer Burden in Young Adults

NCCN

21 May
NCCN

Scalp Cooling for Prevention of Hair Loss in Pediatric ALL - Resonance

Resonance

08 May
Scalp Cooling

8th World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS 2026)

International Federation of Head and Neck Oncologic Societies (IFHNOS)

26 Aug
IFHNOS

Immune-oncology
Immunoradiotherapy With Nivolumab in High-Risk Prostate Cancer

Immunoradiotherapy With Nivolumab in High-Risk Prostate Cancer

NIVIPIT Trial: Can We Reduce Ipilimumab Toxicity Without Losing Efficacy?

Top Phase 3 Immunotherapy Trials at ASCO 2026

RESET-R Trial: One or Two Cycles of Nivolumab + Ipilimumab in dMMR Rectal Cancer

DNA Vaccines + Pembrolizumab in Metastatic Castration-Resistant Prostate cancer

10 Must-Read Posts in Immuno-Oncology This Week

Immunotherapy in Oncology (2025–2026): FDA Approvals and NCCN Evidence

Gastrointestinal-Oncology
COLOSOTO

COLOSOTO Trial: Sotorasib + Panitumumab + 5-FU as 1L Therapy in KRAS G12C Mutated Colorectal Cancer

Top 10 Hepatobiliary Cancer Updates - April 2026

10 Must-Read Posts In GI Oncology This Week

10 Must-Read Posts In GI Oncology This Week

BBOpCo at AACR 2026: First-Line BOT/BAL in Selected MSS Colorectal Cancer Population

Promising Phase I Results for BOT/BAL and agenT-797 in PD-1 Refractory Gastroesophageal Cancer

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
SERENA-6 Trial

SERENA-6 Trial at ESMO Breast Cancer Congress 2026: Ongoing ctDNA Monitoring for ESR1 Mutations in Advanced  Breast Cancer

SMART Trial at ESMO Breast Cancer Annual Congress 2026: ctDNA Tool Predicts Progression Risk in Metastatic Breast Cancer

CAPItello-291: Final OS Data Show No Significant Survival Benefit, but Capivasertib Plus Fulvestrant Extends Disease Control

TROPION-Breast02: Datopotamab Deruxtecan Preserves Quality of Life in First-Line Metastatic TNBC

evERA Breast Cancer Trial: Giredestrant Plus Everolimus Maintains Quality of Life With Manageable Toxicity

PHERGain-2 Trial at ESMO Breast Cancer Congress 2026: Chemo-Free Strategy in HER2+ Early Breast Cancer

ESMO Breast Cancer Annual Congress 2026: DESTINY-Breast11 RCB Analysis Highlights Neoadjuvant T-DXd-THP in HER2-Positive Early Breast Cancer

Lung-Oncology
FRONT-BRAF

FRONT-BRAF: Should Immunotherapy Come First in BRAF V600E-Mutated Metastatic NSCLC?

Pembrolizumab Injection: Powerful 1-Minute Shift in Lung Cancer Care

Datopotamab Deruxtecan in NSCLC: TROP2-Directed ADC Therapy Arrives With an EGFR-Specific Approval and First-Line Ambitions

TRACERx–PEACE Study Maps How Lung Cancer Metastases Evolve From Diagnosis To Death

KRAS G12C Inhibitors In NSCLC: From “Undruggable” To First-Line Contender

Osimertinib After Chemoradiotherapy in Stage III EGFR-Mutated NSCLC: LAURA Redefines the Standard of Care

KIRHub Opens A New Repurposing Map For Kinase Inhibitors In Lung Cancer

OncoDaily TV
Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

European Conference on Interventional Oncology Jean Palussière

Highlights from The European Conference on Interventional Oncology ECIO 2026

Journey from Botswana South Africa

A Journey from Botswana to the Frontlines of Global Health Leadership։ Shenaaz El Halabi

Giuseppe Caruso SGO 2026 Congress Highlights

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology – Key Takeaways with Giuseppe Caruso

RichardGoldberg

Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer

A new partnership to take cancer vaccines from research to care - with Karen Knudsen and Kristen Dahlgren

A new partnership to take cancer vaccines from research to care – with Karen Knudsen and Kristen Dahlgren

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Noetic Medicine: The Science Behind Healing Through Words

Noetic Medicine: The Science Behind Healing Through Words

Not To Miss
ASBrS2026 - OncoDaily

15 Posts Not To Miss From ASBrS2026

10 Must-Read Posts In GI Oncology This Week

Lung Cancer Hope Month 2026: Celebrating Progress in Modern Oncology

Highlights From How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

Head and Neck Cancer Awareness Month 2026: The Urgency of Early Diagnosis in Modern Oncology

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology - Key Takeaways with Giuseppe Caruso

20 Posts Not To Miss From Lung Cancer Europe 2026 Conference

OncoGrants
Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Pediatric Cancer Research Foundation (PCRF) — Emerging Investigator Fellowship Grant

Pediatric Cancer Research Foundation (PCRF) — Emerging Investigator Fellowship Grant

Alex's Lemonade Stand Foundation — 'A' Award Grant

Alex's Lemonade Stand Foundation — 'A' Award Grant

Alex's Lemonade Stand Foundation — R Accelerator Grant

Alex's Lemonade Stand Foundation — R Accelerator Grant

Alex's Lemonade Stand Foundation — Bio-Therapeutics Impact Grant

Alex's Lemonade Stand Foundation — Bio-Therapeutics Impact Grant

Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)

Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
AML

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

CancerWorld

Oncologists
Miriam Mutebi

Miriam Mutebi

Oncologists Location Nairobi, Kenya
Mounir Bachouchi

Mounir Bachouchi

Oncologists Location Rabat, Morocco
Amalya Sargsyan

Amalya Sargsyan

Oncologists Location Yerevan, Armenia
Dirk Arnold

Dirk Arnold

Oncologists Location Hamburg, Germany
Giuseppe Caruso

Giuseppe Caruso

Oncologists Location Milan, Italy
Imène Hadji

Imène Hadji

Oncologists Location Guelma, Algeria
LIdia Schapira

Lidia Schapira

Oncologists Location Stanford, USA
Jean-Yves Blay

Jean-Yves Blay

Oncologists Location Lyon, France

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research